Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Farnaz Hosseini Kamal"'
Publikováno v:
Pathology & Oncology Research. 25:1599-1605
We decided to compare pathologic complete response (pCR) and disease-free survival (DFS) in rectal adenocarcinoma patients who received neoadjuvant chemoradiotherapy (CRT) with capecitabine plus oxaliplatin (XELOX) or capecitabine (Xeloda). In this s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3822c700fcfa22f6659c4dae9b53c0a9
https://doi.org/10.1007/s12253-019-00587-3
https://doi.org/10.1007/s12253-019-00587-3
Publikováno v:
Iranian Journal of Cancer Prevention
Background Considering the hygiene facilities and sharing the data of diseases, considerable attempts to promote the public awareness have been made by various media; however, most of the provided information is based on numerical and verbal statisti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53ceda0410799c3cb9fe5edbdca3be79
https://pubmed.ncbi.nlm.nih.gov/27482327
https://pubmed.ncbi.nlm.nih.gov/27482327
Autor:
Ahamd Ameri, Shiva Moghadam, Kambiz Novin, Farnaz Hosseini Kamal, Nafiseh Mortazavi, Helaleh Khoshbakht Ahmadi
Publikováno v:
Reports of Radiotherapy and Oncology. 2
Background:: Serum creatinine level is frequently used as a measure for renal function assessment. However, there are some situations in which patients may suffer significant renal impairment but serum creatinine levels remain within normal ranges. O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f34a2b8218abc15b50940d3107f6ac3a
https://doi.org/10.17795/rro-3093
https://doi.org/10.17795/rro-3093
Publikováno v:
Chemotherapy. 61(1)
Background: The aim of this study was to compare the efficacy and hematologic toxicity of cetuximab combined with various types of chemotherapy regimens in patients with KRAS wild-type metastatic colorectal cancer (mCRC). Methods: The response rate,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffa31717ab720a0daba54fc7fa1fc718
https://pubmed.ncbi.nlm.nih.gov/26528862
https://pubmed.ncbi.nlm.nih.gov/26528862
Autor:
Mitra Rafizadeh, Saadat Molanaei, Seyed Ahmad Aleyasin, Naser Rakhshani, Payam Azadeh, Farnaz Hosseini Kamal, Ali Ghanbari Motlagh, Mohamad Hashemi, Christer Larsson
Publikováno v:
Annals of Oncology. 23:iv80
Introduction Gastro-Intestinal (GI) cancers are the most common cancer types and leading cause of cancer death in Iran. Genetic abnormalities in TS and ERCC1 have seen in GI cancers frequently and associated to chemotherapy response. The aim of this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0aa76246660cc673233be56b1f33bd5
https://doi.org/10.1016/s0923-7534(20)30097-1
https://doi.org/10.1016/s0923-7534(20)30097-1